Shanghai Chenguang Medical Technologies Co (BJSE:920300) Cyclically Adjusted Book per Share: ¥2.77 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920300 Shanghai Chenguang Medical Technologies Co Ltd BJSE:920300
53 GF Score
Price ¥9.47
GF Value ¥6.57
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Shanghai Chenguang Medical Technologies Co Cyclically Adjusted Book per Share?

Shanghai Chenguang Medical Technologies Co BJSE:920300 53 Cyclically Adjusted Book per Share is ¥2.77 as of Mar. 2026. GuruFocus rates BJSE:920300 with a GF Score™ of 53/100 and a GF Value™ of ¥6.57 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Shanghai Chenguang Medical Technologies Co's adjusted book value per share for the three months ended in Mar. 2026 was ¥1.868. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥2.77 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Shanghai Chenguang Medical Technologies Co's average Cyclically Adjusted Book Growth Rate was 1.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-20), Shanghai Chenguang Medical Technologies Co's current stock price is ¥9.47. Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ¥2.77. Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted PB Ratio of today is 3.42.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Chenguang Medical Technologies Co was 8.05. The lowest was 2.62. And the median was 5.00.


Shanghai Chenguang Medical Technologies Co  (BJSE:920300) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=9.47/2.77
=3.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Shanghai Chenguang Medical Technologies Co was 8.05. The lowest was 2.62. And the median was 5.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Shanghai Chenguang Medical Technologies Co Cyclically Adjusted Book per Share Related Terms


Shanghai Chenguang Medical Technologies Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Chenguang Medical Technologies Co Cyclically Adjusted Book per Share Chart

Shanghai Chenguang Medical Technologies Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 2.69 2.78

Shanghai Chenguang Medical Technologies Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.72 2.74 2.77 2.78 2.77

BJSE:920300 vs VRT, BE: Cyclically Adjusted Book per Share Comparison

For the Electrical Equipment & Parts subindustry, Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Chenguang Medical Technologies Co Cyclically Adjusted PB Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted PB Ratio falls into.


BJSE:920300
53GF Score
Shanghai Chenguang Medical Technologies Co Ltd BJSE:920300
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Chenguang Medical Technologies Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Shanghai Chenguang Medical Technologies Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.868/116.3033*116.3033
=1.868

Current CPI (Mar. 2026) = 116.3033.

Shanghai Chenguang Medical Technologies Co Quarterly Data

Book Value per Share CPI Adj_Book
201512 2.265 100.600 2.619
201606 2.389 101.400 2.740
201612 2.361 102.600 2.676
201703 0.000 103.200 0.000
201706 2.425 103.100 2.736
201709 0.000 104.100 0.000
201712 2.497 104.500 2.779
201803 2.490 105.300 2.750
201806 2.538 104.900 2.814
201809 2.593 106.600 2.829
201812 2.007 106.500 2.192
201903 2.712 107.700 2.929
201906 2.767 107.700 2.988
201909 2.779 109.800 2.944
201912 2.043 111.200 2.137
202003 2.779 112.300 2.878
202006 2.798 110.400 2.948
202009 2.853 111.700 2.971
202012 2.103 111.500 2.194
202103 0.000 112.662 0.000
202106 2.175 111.769 2.263
202109 0.000 112.215 0.000
202112 2.393 113.108 2.461
202203 2.335 114.335 2.375
202206 2.340 114.558 2.376
202209 2.490 115.339 2.511
202212 3.542 115.116 3.579
202303 3.539 115.116 3.576
202306 3.530 114.558 3.584
202309 3.425 115.339 3.454
202312 3.366 114.781 3.411
202403 3.261 115.227 3.291
202406 3.236 114.781 3.279
202409 3.181 115.785 3.195
202412 2.657 114.893 2.690
202503 2.557 115.116 2.583
202506 2.484 114.907 2.514
202509 2.432 115.471 2.450
202512 1.953 115.832 1.961
202603 1.868 116.303 1.868

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ¥2.77 mean?
Shanghai Chenguang Medical Technologies Co (BJSE:920300) has a Cyclically Adjusted Book per Share of ¥2.77 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors.
Is Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted Book per Share too high?
Shanghai Chenguang Medical Technologies Co's current Cyclically Adjusted Book per Share is ¥2.77. Overall, Shanghai Chenguang Medical Technologies Co has a GF Score™ of 53/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted Book per Share compare to VRT and BE?
Shanghai Chenguang Medical Technologies Co's Cyclically Adjusted Book per Share of ¥2.77 can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for an Industrial Products company?
A good Cyclically Adjusted Book per Share depends on the Industrial Products industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Shanghai Chenguang Medical Technologies Co and its competitors. Shanghai Chenguang Medical Technologies Co's current Cyclically Adjusted Book per Share is ¥2.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Chenguang Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co (BJSE:920300) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥6.57, compared to a current price of ¥9.47 — trading 44.1% above its estimated fair value. The current Cyclically Adjusted Book per Share is ¥2.77. Shanghai Chenguang Medical Technologies Co's overall GF Score™ is 53/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Shanghai Chenguang Medical Technologies Co (BJSE:920300), the current Cyclically Adjusted Book per Share is ¥2.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Chenguang Medical Technologies Co (BJSE:920300) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Chenguang Medical Technologies Co stock appears to be overvalued. The current stock price of ¥9.47 is trading 44.1% above its estimated GF Value™ of ¥6.57. GuruFocus considers Shanghai Chenguang Medical Technologies Co to be Significantly Overvalued.

Key valuation signals for BJSE:920300:

  • Cyclically Adjusted Book per Share: ¥2.77
  • GF Value™: ¥6.57 vs. price of ¥9.47 (44.1% above fair value)
  • GF Score™: 53/100 with 6 warning signs

No single metric tells the full story. See the BJSE:920300 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Chenguang Medical Technologies Co Business Description

Address No. 1269, Huaqing Road, Qingpu District, Shanghai, CHN, 201707
Shanghai Chenguang Medical Technologies Co Ltd engages in research and development, production, and sales of the core hardware of medical imaging superconducting MRI equipment and special magnets in the field of scientific research. The company's product system covers hardware of superconducting MRI devices, including: RF detectors, superconducting magnets, gradient coils, RF amplifiers, gradient amplifiers.
53GF Score

Get the complete analysis for BJSE:920300

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.47
Price
¥6.57
GF Value